Cacna1a Disorders clinical trials

Explore recruiting cacna1a disorders clinical trials.

Also recruiting in Europe

Cacna1a Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IB1001-304: Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, randomized, placebo-controlled, double-blind, crossover study

Italy, Germany, Austria, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cacna1a Disorders trials by city

Cacna1a Disorders in Toronto Cacna1a Disorders in Vancouver Cacna1a Disorders in Montreal Cacna1a Disorders in Calgary Cacna1a Disorders in Edmonton Cacna1a Disorders in Ottawa Cacna1a Disorders in Winnipeg Cacna1a Disorders in Quebec City Cacna1a Disorders in Hamilton Cacna1a Disorders in Kitchener Cacna1a Disorders in London Cacna1a Disorders in Halifax Cacna1a Disorders in New York Cacna1a Disorders in Los Angeles Cacna1a Disorders in Chicago Cacna1a Disorders in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease